Literature DB >> 25312952

Persistence and toxin production by Clostridium difficile within human intestinal organoids result in disruption of epithelial paracellular barrier function.

Jhansi L Leslie1, Sha Huang2, Judith S Opp3, Melinda S Nagy2, Masayuki Kobayashi4, Vincent B Young5, Jason R Spence6.   

Abstract

Clostridium difficile is the leading cause of infectious nosocomial diarrhea. The pathogenesis of C. difficile infection (CDI) results from the interactions between the pathogen, intestinal epithelium, host immune system, and gastrointestinal microbiota. Previous studies of the host-pathogen interaction in CDI have utilized either simple cell monolayers or in vivo models. While much has been learned by utilizing these approaches, little is known about the direct interaction of the bacterium with a complex host epithelium. Here, we asked if human intestinal organoids (HIOs), which are derived from pluripotent stem cells and demonstrate small intestinal morphology and physiology, could be used to study the pathogenesis of the obligate anaerobe C. difficile. Vegetative C. difficile, microinjected into the lumen of HIOs, persisted in a viable state for up to 12 h. Upon colonization with C. difficile VPI 10463, the HIO epithelium is markedly disrupted, resulting in the loss of paracellular barrier function. Since similar effects were not observed when HIOs were colonized with the nontoxigenic C. difficile strain F200, we directly tested the role of toxin using TcdA and TcdB purified from VPI 10463. We show that the injection of TcdA replicates the disruption of the epithelial barrier function and structure observed in HIOs colonized with viable C. difficile.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25312952      PMCID: PMC4288864          DOI: 10.1128/IAI.02561-14

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin.

Authors:  Matthias Bruewer; Ann M Hopkins; Michael E Hobert; Asma Nusrat; James L Madara
Journal:  Am J Physiol Cell Physiol       Date:  2004-03-24       Impact factor: 4.249

2.  Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.

Authors:  E Chaves-Olarte; M Weidmann; C Eichel-Streiber; M Thelestam
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Arx is required for normal enteroendocrine cell development in mice and humans.

Authors:  Aiping Du; Kyle W McCracken; Erik R Walp; Natalie A Terry; Thomas J Klein; Annie Han; James M Wells; Catherine Lee May
Journal:  Dev Biol       Date:  2012-02-24       Impact factor: 3.582

4.  Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains.

Authors:  Casey M Theriot; Charles C Koumpouras; Paul E Carlson; Ingrid I Bergin; David M Aronoff; Vincent B Young
Journal:  Gut Microbes       Date:  2011-11-01

5.  Generating human intestinal tissue from pluripotent stem cells in vitro.

Authors:  Kyle W McCracken; Jonathan C Howell; James M Wells; Jason R Spence
Journal:  Nat Protoc       Date:  2011-11-10       Impact factor: 13.491

6.  Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A.

Authors:  Tim Du; Michelle J Alfa
Journal:  Can J Infect Dis       Date:  2004-03

7.  Identification of site-specific degradation in bacterially expressed human fibroblast growth factor 4 and generation of an aminoterminally truncated, stable form.

Authors:  Saiko Sugawara; Toshihiko Ito; Shiori Sato; Yuki Sato; Kano Kasuga; Ikuo Kojima; Masayuki Kobayashi
Journal:  Appl Biochem Biotechnol       Date:  2013-09-26       Impact factor: 2.926

8.  R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis.

Authors:  Sheila M Bell; Claire M Schreiner; Susan E Wert; Michael L Mucenski; William J Scott; Jeffrey A Whitsett
Journal:  Development       Date:  2008-02-06       Impact factor: 6.868

9.  Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro.

Authors:  Jason R Spence; Christopher N Mayhew; Scott A Rankin; Matthew F Kuhar; Jefferson E Vallance; Kathryn Tolle; Elizabeth E Hoskins; Vladimir V Kalinichenko; Susanne I Wells; Aaron M Zorn; Noah F Shroyer; James M Wells
Journal:  Nature       Date:  2010-12-12       Impact factor: 49.962

10.  Stem cell-derived human intestinal organoids as an infection model for rotaviruses.

Authors:  Stacy R Finkbeiner; Xi-Lei Zeng; Budi Utama; Robert L Atmar; Noah F Shroyer; Mary K Estes
Journal:  MBio       Date:  2012-07-03       Impact factor: 7.867

View more
  136 in total

Review 1.  Physiologically relevant human tissue models for infectious diseases.

Authors:  Melody Mills; Mary K Estes
Journal:  Drug Discov Today       Date:  2016-06-25       Impact factor: 7.851

Review 2.  Intestinal Organoids: New Frontiers in the Study of Intestinal Disease and Physiology.

Authors:  Thomas E Wallach; James R Bayrer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

Review 3.  Intestinal organoids in infants and children.

Authors:  Sinobol Chusilp; Bo Li; Dorothy Lee; Carol Lee; Paisarn Vejchapipat; Agostino Pierro
Journal:  Pediatr Surg Int       Date:  2019-09-25       Impact factor: 1.827

4.  Long-term flow through human intestinal organoids with the gut organoid flow chip (GOFlowChip).

Authors:  Barkan Sidar; Brittany R Jenkins; Sha Huang; Jason R Spence; Seth T Walk; James N Wilking
Journal:  Lab Chip       Date:  2019-10-09       Impact factor: 6.799

Review 5.  Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age.

Authors:  Jennifer Barrila; Aurélie Crabbé; Jiseon Yang; Karla Franco; Seth D Nydam; Rebecca J Forsyth; Richard R Davis; Sandhya Gangaraju; C Mark Ott; Carolyn B Coyne; Mina J Bissell; Cheryl A Nickerson
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

Review 6.  Insights into the role of the intestinal microbiota in colon cancer.

Authors:  Sofia Oke; Alberto Martin
Journal:  Therap Adv Gastroenterol       Date:  2017-02-01       Impact factor: 4.409

7.  Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.

Authors:  Jenessa A Winston; Rajani Thanissery; Stephanie A Montgomery; Casey M Theriot
Journal:  J Vis Exp       Date:  2016-12-10       Impact factor: 1.355

8.  Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs.

Authors:  Eva S Rodansky; Laura A Johnson; Sha Huang; Jason R Spence; Peter D R Higgins
Journal:  Exp Mol Pathol       Date:  2015-03-28       Impact factor: 3.362

9.  FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction.

Authors:  Shi-Yi Zhou; Merritt Gillilland; Xiaoyin Wu; Pornchai Leelasinjaroen; Guanpo Zhang; Hui Zhou; Bo Ye; Yuanxu Lu; Chung Owyang
Journal:  J Clin Invest       Date:  2017-11-27       Impact factor: 14.808

10.  Human Gastrointestinal Organoid Models for Studying Microbial Disease and Cancer.

Authors:  Jayati Chakrabarti; Martha B Dua-Awereh; Loryn Holokai; Yana Zavros
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.